Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$824M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$459M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
| 4 |
Warner Bros
WBD
|
+$287M |
| 5 |
Tesla
TSLA
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.88B |
| 2 |
AT&T
T
|
+$530M |
| 3 |
Meta Platforms (Facebook)
META
|
+$481M |
| 4 |
Workday
WDAY
|
+$462M |
| 5 |
Apple
AAPL
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.22% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 1.52% |
| 4 | Communication Services | 1.04% |
| 5 | Financials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
PUT
Brunswick
BC
$4.97B
| $4.67M | ﹤0.01% |
71,500
+5,900
| +9% | +$434K |
|
3252
Energizer
ENR
$1.53B
| $4.67M | ﹤0.01% |
164,652
+2,909
| +2% | +$87.5K |
|
3253
Lumentum
LITE
$80.3B
| $4.67M | ﹤0.01% |
58,784
+17,875
| +44% | +$1.53M |
|
|
BHVN
3254
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.66M | ﹤0.01% |
31,995
+17,851
| +126% | +$2.28M |
|
3255
PUT
Voya Financial
VOYA
$9.29B
| $4.65M | ﹤0.01% |
78,100
+61,500
| +370% | +$3.96M |
|
3256
CALL
Arthur J. Gallagher & Co
AJG
$68.6B
| $4.65M | ﹤0.01% |
28,500
-2,200
| -7% | -$365K |
|
|
ERF
3257
PUT
DELISTED
Enerplus Corporation
ERF
| $4.65M | ﹤0.01% |
351,200
+122,700
| +54% | +$1.69M |
|
3258
Exelixis
EXEL
$13.5B
| $4.64M | ﹤0.01% |
223,007
+28,915
| +15% | +$596K |
|
3259
ROBO Global Robotics & Automation Index ETF
ROBO
$2.05B
| $4.64M | ﹤0.01% |
103,223
+17,962
| +21% | +$897K |
|
3260
CALL
PAR Technology
PAR
$792M
| $4.64M | ﹤0.01% |
123,700
+17,200
| +16% | +$618K |
|
3261
Jacobs Solutions
J
$17.8B
| $4.64M | ﹤0.01% |
44,092
-72,250
| -62% | -$8.09M |
|
3262
CALL
Tower Semiconductor
TSEM
$23.5B
| $4.64M | ﹤0.01% |
100,400
-87,400
| -47% | -$4.16M |
|
3263
Gartner
IT
$12.5B
| $4.61M | ﹤0.01% |
19,067
-4,303
| -18% | -$1.14M |
|
3264
CALL
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
| $4.61M | ﹤0.01% |
35,600
-12,700
| -26% | -$1.8M |
|
3265
CALL
Matsons
MATX
$6.71B
| $4.6M | ﹤0.01% |
63,100
+800
| +1% | +$68.8K |
|
3266
PUT
Relmada Therapeutics
RLMD
$462M
| $4.6M | ﹤0.01% |
242,200
+207,400
| +596% | +$4.52M |
|
3267
Amplify Alternative Harvest ETF
MJ
$117M
| $4.6M | ﹤0.01% |
66,064
-11,164
| -14% | -$1.03M |
|
3268
CALL
Helen of Troy
HELE
$667M
| $4.6M | ﹤0.01% |
28,300
+18,800
| +198% | +$3.54M |
|
3269
Affirm
AFRM
$26.2B
| $4.59M | ﹤0.01% |
254,404
-402,776
| -61% | -$11M |
|
3270
PUT
Sarepta Therapeutics
SRPT
$2.2B
| $4.59M | ﹤0.01% |
61,300
-13,500
| -18% | -$993K |
|
3271
Camden Property Trust
CPT
$12.3B
| $4.59M | ﹤0.01% |
+34,154
| New | +$5.06M |
|
3272
Ginkgo Bioworks
DNA
$469M
| $4.59M | ﹤0.01% |
48,230
-30,881
| -39% | -$3.77M |
|
3273
Mueller Water Products
MWA
$3.81B
| $4.59M | ﹤0.01% |
391,331
+159,648
| +69% | +$1.92M |
|
3274
CALL
Iovance Biotherapeutics
IOVA
$3.63B
| $4.59M | ﹤0.01% |
415,600
+115,900
| +39% | +$1.52M |
|
|
NEWR
3275
CALL
DELISTED
New Relic, Inc.
NEWR
| $4.58M | ﹤0.01% |
91,600
-19,600
| -18% | -$1.09M |
|
Similar funds
Jeff Yass's Q2 2022 Portfolio in Review
As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
- Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
- Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
- Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
- Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
- Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
- Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.